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ABSTRACT Listeria monocytogenes is a pathogenic bacterium causing potentially fa-
tal foodborne infections in humans and animals. While the mechanisms used by Lis-
teria to manipulate its host have been thoroughly characterized, how the host con-
trols bacterial virulence factors remains to be extensively deciphered. Here, we
found that the secreted Listeria virulence protein InlC is monoubiquitinated by the
host cell machinery on K224, restricting infection. We show that the ubiquitinated
form of InlC interacts with the intracellular alarmin S100A9, resulting in its stabiliza-
tion and in increased reactive oxygen species production by neutrophils in infected
mice. Collectively, our results suggest that posttranslational modification of InlC ex-
acerbates the host response upon Listeria infection.
IMPORTANCE The pathogenic potential of Listeria monocytogenes relies on the pro-
duction of an arsenal of virulence determinants that have been extensively charac-
terized, including surface and secreted proteins of the internalin family. We have
previously shown that the Listeria secreted internalin InlC interacts with IB kinase 
to interfere with the host immune response (E. Gouin, M. Adib-Conquy, D. Balestrino,
M.-A. Nahori, et al., Proc Natl Acad Sci USA, 107:17333–17338, 2010, https://doi.org/10
.1073/pnas.1007765107). In the present work, we report that InlC is monoubiquitinated
on K224 upon infection of cells and provide evidence that ubiquitinated InlC interacts
with and stabilizes the alarmin S100A9, which is a critical regulator of the immune
response and inflammatory processes. Additionally, we show that ubiquitination of InlC
causes an increase in reactive oxygen species production by neutrophils in mice and
restricts Listeria infection. These findings are the first to identify a posttranscriptional
modification of an internalin contributing to host defense.
KEYWORDS Listeria monocytogenes, ubiquitination, pathogenesis, alarmin,
inflammation
Listeria monocytogenes is a Gram-positive bacterium widespread in the environmentand the etiological agent of listeriosis, a life-threatening foodborne disease. It is
responsible for gastroenteritis in healthy individuals, meningitis, septicemia in immu-
nocompromised individuals, miscarriages in pregnant women, and perinatal infections
(1). Following ingestion of contaminated food, L. monocytogenes is able to cross the
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intestinal barrier, to reach the liver and spleen through the lymph and the bloodstream,
and to disseminate to the brain and placenta after crossing the blood-brain barrier and
the maternofetal barrier, respectively (2). At the cell level, this bacterium has the ability
to invade, survive, and replicate intracellularly within professional phagocytes and a
number of nonphagocytic cells, to spread from cell to cell, escaping host immunity.
Upon infection of the host, L. monocytogenes employs a series of virulence factors that
control host molecules and hijack cellular processes (3). The main invasion proteins,
InlA and InlB, promote bacterial entry into nonphagocytic cells by interacting with the
surface receptors E-cadherin and c-Met, respectively (4–7). The secreted listeriolysin O
(LLO) and phospholipases (PlcA and PlcB) disrupt the primary and secondary vacuoles
and allow the escape of the bacterium into the cytoplasm (8–10). ActA mimics the host
actin polymerization machinery to promote motility, allowing intercellular spread and
protection from autophagy (11, 12, 13). All the virulence factors cited above are
positively controlled by the transcriptional activator PrfA (6, 13, 14). Inactivation of PrfA
or that of the major virulence factors, e.g., LLO or ActA, leads to severe attenuation of
Listeria virulence in animal models of infection (11, 13, 15). Other factors have a more
moderate role in virulence, yet they are important for specific cellular processes, tissue
types, or stages of the infectious process. This is the case for InlC, whose inactivation
leads to a 0.5- to 1.5-log increase in the 50% lethal dose (LD50) after intravenous
inoculation in mice (16, 17). InlC is a secreted protein of the Listeria internalin family
whose expression is positively regulated by PrfA (18, 19). It is highly expressed by
Listeria after its internalization inside host cells (20). InlC has several functions in host
cells. We previously reported that it interacts with IKK-, impairs the phosphorylation
of IB- and delays the degradation of phospho-IB-, thereby impairing NF-B
translocation to the nucleus and subsequently dampening the host innate response, in
particular genes encoding proinflammatory cytokines (16). Interestingly, InlC has also
been shown to bind the scaffolding protein Tuba in polarized human cells (21). Tuba
and its effectors N-WASP and CDC42 form a complex that generates tension at apical
junctions of polarized cells. InlC inhibits the interaction between N-WASP and Tuba and
thereby promotes relaxation of cortical actin tension, protrusion formation, and bac-
terial cell-to-cell spread.
S100A9, also named myeloid-related protein 14 (MRP14) or calgranulin B, is a
member of the S100 family of calcium-binding proteins and forms a heterodimeric
complex with S100A8, also known as MRP8 or calgranulin A, which is involved in
inflammation (22, 23). This heterodimeric complex (calprotectin) is constitutively and
highly expressed in neutrophils. In monocytes, macrophages, and endothelial cells,
S100A8/S100A9 expression is induced by bacterial products such as lipopolysaccharide,
proinflammatory cytokines such as tumor necrosis factor alpha (TNF-), or anti-
inflammatory cytokines such as interleukin-10 (IL-10) (24). These antimicrobial proteins
act as danger signals in vertebrates and are called damage-associated molecular
patterns (DAMPs) or alarmins. They indirectly prevent bacterial adhesion to the mucosal
epithelium and inhibit bacterial growth through nutrient metal chelation (25). Clinical
data show clear correlations between the concentration of these proteins in the serum
or synovial fluid of patients with chronic inflammatory diseases and pathogenesis (26).
In addition to their antimicrobial properties, these proteins have been shown to be
involved in neutrophil activation and migration to inflammatory sites (23, 27).
In this study, we found that InlC is monoubiquitinated by the host cell machinery on
K224, restricting infection. This ubiquitinated form of InlC interacts with and stabilizes
the intracellular alarmin S100A9, resulting in increased reactive oxygen species (ROS)
production by neutrophils in infected mice. Together, our data highlight that post-
translational modification of InlC contributes to the host response upon Listeria infec-
tion.
RESULTS
The L. monocytogenes InlC protein is ubiquitinated in infected epithelial cells.
We reexamined the expression of InlC by L. monocytogenes during infection of HeLa
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cells. As we previously showed (16), InlC is gradually secreted during infection (Fig. 1A).
In addition to the secreted InlC mature form (30 kDa, without a signal peptide), we
observed, using immunoblot experiments with anti-InlC antibodies, other higher-
molecular-weight species, including a major 47-kDa band (InlCH) (Fig. 1A). The differ-
ence in molecular weights between these proteins prompted us to examine whether
these forms could correspond to InlC posttranslationally modified by ubiquitin or
ubiquitin-like proteins (UBLs), such as interferon-stimulated gene 15 (ISG15) and SUMO.
HeLa cells were infected with the wild-type (WT) L. monocytogenes EGD strain or a ΔinlC
mutant for 24 h and lysed, and total cell extracts were immunoprecipitated with
anti-InlC antibodies. Immunoprecipitates were analyzed by immunoblot experiments
using anti-InlC, antiubiquitin, anti-ISG15, and anti-SUMO1 antibodies. As shown in
FIG 1 InlC is modified. (A) Time course analysis of InlC expression in cells infected with L. monocytogenes
EGD. Total HeLa cell extracts at different time points after infection were analyzed by Western blotting
using anti-InlC and antiactin antibodies. Actin is used as a loading control. The arrows highlight the main
InlC forms, InlC and InlCH. MM, molecular mass. (B) InlC is ubiquitinated. Total cell lysates of HeLa cells,
noninfected (NI) or infected with the wild-type (WT) or the inlC mutant (ΔinlC) strains, were immuno-
precipitated (IP) with anti-InlC antibodies, followed by immunoblotting with antiubiquitin (mouse FK2,
catalog number BML-PW8810; Enzo Life), anti-SUMO1 (catalog number 4930S; Cell Signaling Technol-
ogy), or anti-ISG15 (mouse F-9, catalog number sc166755; Santa Cruz) antibodies. Note that the
anti-SUMO1 antibodies recognized nonspecifically (NS) the InlC protein. (C) Schematic representation of
InlC indicating the locations of lysine residues within the whole protein. SP, signal peptide; LRRs,
leucine-rich repeats. (D) Identification of the InlC ubiquitination sites. Shown is the effect of mutations
of InlC lysine residues on its expression in cells. Total cell lysates of HeLa cells, noninfected or infected
for 24 h with the mutants, were immunoblotted with anti-InlC antibodies. Numbers indicate the positions
of lysine residues according to the diagram shown in panel C. The data shown are representative of
independent data from at least three experiments.
Listeria InlC Ubiquitination Supports Host Response ®
November/December 2019 Volume 10 Issue 6 e02778-19 mbio.asm.org 3
 on M










Fig. 1B, the major larger form of InlC, i.e., InlCH, was detected only by antiubiquitin
antibodies in cells infected with the WT strain but not in cells infected with the ΔinlC
mutant and not by anti-UBL antibodies, suggesting that this form corresponds to
ubiquitinated InlC.
InlC protein is ubiquitinated on lysine 224. In order to map the InlC ubiquitina-
tion site, we generated Listeria strains in which each of the 21 lysine residues of InlC
were replaced, individually or in combination, by arginine residues (Fig. 1C). Two
additional Listeria strains were generated, one in which all lysines have been replaced
by an arginine (InlC-Kall) and the other in which each lysine of the six leucine-rich
repeats (LRRs) has been replaced by an arginine (InlC-KLRR). The different strains were
tested for InlC ubiquitination in epithelial cells infected for 24 h. We noted that each
strain expressed InlC at levels similar to that of the wild-type strain in HeLa cells, except
for the InlC-Kall strain, which produced slightly less InlC (Fig. 1D). As expected, the InlCH
ubiquitinated form could not be detected in the InlC-Kall strain. Strikingly, the level of
the InlCH form appeared significantly decreased in the InlC-K224, InlC-K173,224, and
InlC-K217,224,236,273,296 strains. Interestingly, InlCH of the InlC-K224 mutant was replaced
by a slightly smaller modified form (InlCSw), possibly due to a modification on another
lysine residue, a phenomenon previously observed for other UBL targets (28). However,
the lysine K173, implicated in the binding of InlC to Tuba (21), was not a ubiquitination
site, as the corresponding mutated InlC is still ubiquitinated. Together, these results
demonstrate that InlC is ubiquitinated during infection of epithelial cells, and the major
site of ubiquitination is the lysine residue K224.
InlC is monoubiquitinated upon infection. In order to determine whether InlC is
mono- or polyubiquitinated, HeLa cells were transiently transfected with plasmids
expressing hemagglutinin (HA)-tagged lysineless ubiquitin (Knull), which lacks lysine
residues and does not allow the formation of ubiquitin chains (29), or HA-tagged
SUMO1 as a control (30). Cells were then infected with Listeria encoding native InlC or
InlC-K224. After 24 h of infection, InlC was immunoprecipitated with anti-InlC antibodies.
Immunoprecipitates were separated by SDS-PAGE, and the presence of ubiquitinated
InlC was probed using anti-HA antibodies. The InlCH form was detected in cells
transfected with Knull ubiquitin and infected with Listeria encoding native InlC, sug-
gesting that InlCH corresponds to a monoubiquitinated InlC (Fig. 2). The InlCSw form
was also detected in cells transfected with Knull ubiquitin and infected with bacteria
expressing InlC-K224, reinforcing the hypothesis of a compensatory ubiquitination of
another lysine residue upon K-to-R substitution of lysine 224. For cells transfected with
HA-tagged SUMO1 and infected with Listeria encoding native InlC or InlC-K224, we did
not observe, by immunoprecipitation, a SUMOylated form of InlC. Together, our results
indicate that InlC can be ubiquitinated and that InlCH corresponds to a monoubiquiti-
nation on lysine K224.
InlC ubiquitination contributes to the host response to Listeria infection. To
evaluate if InlC ubiquitination plays a role in the infectious process in vivo, we
compared the LD50s of L. monocytogenes EGD strains expressing WT InlC (InlC-WT) and
those expressing InlC-K224 in female BALB/c mice infected by the intravenous (i.v.)
route. Lysine 224 substitution led to an LD50 of 3  103 CFU, 1 log10 unit lower than
the LD50 of the wild-type strain, which was 3  104 CFU. The survival of mice infected
with 104 L. monocytogenes bacteria expressing InlC-K224 was strongly reduced (Fig. 3A).
In contrast, the whole group of mice infected with the wild-type strain survived and
fully recovered. Thus, ubiquitination of InlC contributes to host protection against
Listeria.
To investigate further the role of InlC ubiquitination in systemic infection, we
infected female C57BL/6 mice intraperitoneally with 1  107 bacteria of wild-type
Listeria or the Listeria strain expressing InlC-K224. The number of bacteria, the number
of immune cells, and ROS production by neutrophils in the peritoneal lavage fluid of
infected animals were determined at 24, 48, and 72 h postinfection. Mutation of K224 in
InlC did not lead to any significant change in the bacterial counts recovered from the
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lavage fluid at these time points (data not shown). We next measured the number of
immune cells by flow cytometry in the same lavage fluids. At 24 h, infection of mice
with Listeria expressing native InlC or InlC-K224 led to a similar recruitment of NK cells,
macrophages, and neutrophils (Fig. 3B to D). At later time points, there was a decrease
in the number of immune cells in the peritoneal lavage fluid of infected mice, which
was marked for neutrophils and more moderate for macrophages and NK cells. As seen
at 24 h, the K224 mutation did not affect significantly the number of phagocytic cells at
48 and 72 h postinfection (Fig. 3B to D). In contrast, the strain producing InlC-K224
triggered weaker ROS production by neutrophils than the WT strain (Fig. 3E). Together,
these results demonstrate that InlC ubiquitination modulates the activation of neutro-
phils upon Listeria infection, without affecting the cell number significantly.
InlC interacts with S100A9. The two known roles of InlC, i.e., inhibition of NF-B
nuclear translocation (16) and promotion of cell-to-cell spread (21), were not affected
by ubiquitination (data not shown). We thus assessed further the role of InlC modifi-
cation during infection by searching putative partners that would interact with native
or nonubiquitinatable InlC. Extracts from HeLa cells infected for 24 h with Listeria
expressing native InlC, InlC-Kall, or InlC-K224 were immunoprecipitated with anti-InlC
antibodies, and the immunoprecipitates were analyzed by liquid chromatography-
tandem mass spectrometry (LC-MS/MS), leading to the identification of the alarmin
S100A9 as a putative interactor of InlC (see Table S1 in the supplemental material). To
confirm this interaction, we transfected HeLa cells with vectors expressing humanized
FLAG-tagged InlC, InlC-Kall, or InlC-K224 and HA-tagged S100A9. Cell lysates were then
immunoprecipitated with anti-FLAG magnetic beads, and immunoprecipitates were
analyzed by immunoblotting with anti-InlC and anti-HA antibodies. As shown in Fig. 4A,
S100A9 coimmunoprecipitated with InlC. Notably, larger amounts of S100A9 were
FIG 2 InlC is monoubiquitinated in epithelial cells upon infection. HeLa cells were transfected with
Knull-HA-ubiquitin or WT HA-SUMO1 and then were noninfected or infected with L. monocytogenes EGD
WT, ΔinlC, or InlC-K224 for 24 h. Cell lysates were subjected to immunoprecipitation with anti-InlC
antibodies, and immunocomplexes were analyzed by immunoblotting using anti-HA and anti-InlC
antibodies. Input fractions are shown as controls. The data shown are representative of independent data
from two experiments.
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detected following immunoprecipitation with native InlC than with InlC-Kall or
InlC-K224.
To further confirm the interaction between S100A9 and InlC, we designed a split-
nanoluciferase (NanoLuc) protein complementation assay (NPCA). Plasmids expressing
S100A9 or native InlC, InlC-Kall, or InlC-K224 fused to two complementary NanoLuc
moieties were cotransfected into cells, and luciferase activity was measured 24 h after
transfection. Coexpression of S100A9 with InlC led to strong luciferase activity, similar
to the intensity observed for S100A9/S100A9 homodimers, confirming the S100A9
interaction with InlC (Fig. 4B). Remarkably, the luciferase intensity was reduced when
S100A9 was coexpressed with InlC-Kall or InlC-K224, in line with the immunoprecipita-
tion data. This indicates that S100A9 interacts to a lesser extent with nonubiquitinat-
able and K224-substituted forms of InlC and, thus, that ubiquitination of InlC promotes
its interaction with S100A9.
Ubiquitination of InlC controls the level of S100A9 and the S100A9-dependent
host response to infection. To investigate the functional significance of InlC ubiquiti-
nation, and to evaluate whether the interaction of ubiquitinated InlC with S100A9 could
modify the level of S100A9, we cotransfected HeLa cells with a plasmid expressing
HA-tagged S100A9 and a plasmid expressing either InlC, InlC-Kall, or InlC-K224 at various
concentrations. Cell extracts were analyzed by immunoblotting with anti-InlC and
anti-HA antibodies. The levels of S100A9 increased when the InlC-WT plasmid was
FIG 3 InlC ubiquitination restricts infection and modulates ROS production by neutrophils in mice. (A)
BALB/c mice were infected by intravenous injection of 104 bacteria of the L. monocytogenes EGD WT or
InlC-K224 strains. Survival was determined daily for 10 days. Comparison of WT and InlC-K224 data was
performed using the Mantel-Cox test. Survival curves were significantly different (P  0.05). (B to E)
C57BL/6 mice were infected by intraperitoneal injection of 107 bacteria of the L. monocytogenes EGD WT
or InlC-K224 strains. Data from two experiments were pooled. The numbers of NK cells (B), macrophages
(C), and neutrophils (D) and the level of ROS produced by neutrophils (E) in peritoneal lavage fluids were
assessed by flow cytometry at 24, 48, and 72 h postinfection. Comparison of WT and InlC-K224 data was
performed using two-way analysis of variance and a Holm-Sidak post hoc test (  0.05). Mean values
with a P value of 0.05 were statistically different (ns, nonsignificant; *, P  0.05; ***, P  0.001). The data
shown are representative of independent data from two to five experiments. MFI, mean fluorescence
intensity.
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transfected (Fig. 5A). The levels of S100A9 remained stable upon further increased
expression of InlC. In contrast, increasing InlC-Kall expression led to a massive decrease
of S100A9, which dropped from detectable to undetectable levels when 0.1 to 0.75 g
of the InlC-Kall plasmid was transfected. Similarly, the expression of InlC-K224 led to the
initial detection of S100A9, which progressively decreased when the production of
InlC-K224 increased, suggesting that ubiquitination of InlC stabilizes S100A9 and pre-
vents its disappearance. A similar trend was observed in HeLa cells transfected with a
plasmid expressing HA-tagged S100A9, whose S100A9 levels were higher upon infec-
tion with Listeria expressing native InlC than upon infection with Listeria expressing
InlC-Kall or InlC-K224 (Fig. S1).
Given that host ubiquitination of InlC contributes to the host response to infection,
we next sought to determine if S100A9 was involved in this response. We infected
S100A9/ mice intraperitoneally with 1  107 bacteria of wild-type Listeria or the
Listeria strain expressing InlC-K224. The number of neutrophils and ROS production by
neutrophils in the peritoneal lavage fluid of infected animals were determined at 24 h
postinfection. Infection of mice with Listeria encoding InlC or InlC-K224 led to a similar
recruitment of neutrophils (Fig. 5B). In contrast to what was observed in S100A9/
mice (Fig. 3E), in S100A9-deficient mice, the WT Listeria strain did not trigger a higher
level of ROS production by neutrophils than the strain producing InlC-K224 (Fig. 5C).
Together, these results demonstrate that InlC ubiquitination modulates the activation
of neutrophils upon Listeria infection in an S100A9-dependent manner.
FIG 4 InlC interacts with S100A9. (A) Interaction of S100A9 with InlC in transfected HeLa cells. Whole-cell lysates
from HeLa cells, nontransfected or transfected with the indicated plasmids, were immunoprecipitated with
anti-FLAG beads, followed by immunoblotting with anti-InlC and anti-HA antibodies. S100A9H corresponds to the
dimeric form of the protein. The data shown are representative of independent data from three experiments. (B)
Luciferase protein complementation assay. HEK-293T cells were transfected with 100 ng of plasmids expressing
each part of the nanoluciferase alone (control [CTRL]) or S100A9 or InlC bearing NanoLuc moiety 1 or 2 at their N
or C terminus. At 24 h posttransfection, the medium of the cells was discarded, and cells were incubated with 50 l
of Nano-Glo reagent. Luciferase enzymatic activity was measured using a Berthold Centro XS LB960 luminometer
and counting luminescence for 2 s. The values represent the means from quadruplicate experiments. Statistical
analysis was performed using a t test. Mean values with P values of 0.05 were statistically different (ns,
nonsignificant; **, P  0.01; ***, P  0.001; ****, P  0.0001). RLU, relative light units.
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Ubiquitinated InlC interacts with S100A9 partners and proteins involved in
S100A9-dependent pathways. To further assess the functional link between ubiqui-
tinated InlC and S100A9, a list of potential common partners of InlC and S100A9 was
established based on the two known interactors of InlC (16, 21), putative interactors of
InlC found in a two-hybrid screen (Table S2), and S100A9 interactors found in the
BioGRID database (Table S3). A total of 67 cDNAs encoding 67 human factors from the
human ORFeome collection (Center for Cancer Systems Biology [CCSB], Dana-Farber
Institute, Boston, MA, USA) as clones in the pDONR223 vector were selected. The
human open reading frames (ORFs) were transferred by Gateway recombination in
fusion with the sequence encoding the Nlc1 fragment of the nanoluciferase into the
destination vector pSNL-N1. The ORFs encoding native InlC, InlC-Kall, or InlC-K224 were
fused to the sequence encoding the complementary Nlc2 fragment of the nanolu-
ciferase into the vector pSNL-C2. HEK-293T cells were cotransfected with pSNL-N1 and
pSNL-C2, and interactions between each partner and the InlC, InlC-Kall, or InlC-K224
protein were assessed by measuring luciferase activity at 24 h posttransfection (Fig. 6A).
The human protein BCL2-L1 was used as a negative control. CHUK/IKK- and Tuba, the
two characterized InlC interactors, were used as positive controls. We focused our
analysis on the difference in interactions between native InlC and InlC-K224. For each
potential partner, the difference in the luciferase signals between the pair partner/InlC
and the pair partner/InlC-K224 was calculated. In total, 29 binary interactions of the 67
pairs were found to be statistically different between InlC and InlC-K224, among which
17 pairs show a reduction of interaction when lysine residue 224 was mutated (Fig. 6B).
FIG 5 Ubiquitination of InlC controls the levels of S100A9 and ROS production by neutrophils in an S100A9-
dependent manner. (A) HeLa cells were nontransfected or cotransfected with a plasmid encoding HA-tagged
S100A9 and increasing amounts of a plasmid encoding either native InlC, InlC-Kall, or InlC-K224. Whole-cell lysates
were analyzed by immunoblotting with anti-InlC and anti-HA antibodies. The data shown are representative of
independent data from three experiments. (B and C) S100A9/ mice were infected by intraperitoneal injection
of 107 bacteria of the L. monocytogenes EGD WT or InlC-K224 strains. The number of neutrophils (B) and the level
of ROS produced by neutrophils (C) in peritoneal lavage fluids were assessed by flow cytometry at 24 h postin-
fection. Comparison of WT and InlC-K224 data was performed using a t test. Mean values with P values of 0.05 were
statistically different (ns, nonsignificant; *, P  0.05). The data shown are representative of independent data from
two experiments.
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Thus, these proteins could interact better with ubiquitinated InlC than with InlC-K224.
On the other hand, we identified 12 pairs with an increased interaction when InlC was
not ubiquitinated (Fig. 6B). Among the 29 interactors, 5 proteins are known to be direct
ligands of S100A9: cullin-2 (Cul2) and cullin-5, two members of the cullin-RING E3
ubiquitin ligase (CRL) complexes; the PPP2R1A and PPP2R2A subunits of serine/threo-
FIG 6 Ubiquitinated InlC interacts with S100A9 partners. (A) Heat map representing interactions of cellular proteins
with native InlC, InlC-Kall, or InlC-K224. A total of 67 selected human ORFs were fused to the sequence encoding the
Nlc1 fragment of the nanoluciferase in pSNL-N1. The ORFs encoding native InlC, InlC-Kall, or InlC-K224 were fused
to the sequence encoding the complementary Nlc2 fragment of the nanoluciferase in pSNL-C2. HEK-293T cells
were cotransfected with pSNL-N1 and pSNL-C2, and interactions between each cellular protein and InlC, InlC-Kall,
or InlC-K224 were assessed by measuring luciferase activity at 24 h posttransfection. BCL2-L1 was used as a negative
control, and S100A9 was used as a positive control. Light blue-to-dark blue colors indicate weak-to-strong
interactions. Values of the normalized luciferase signals correspond to the means of log-transformed data. The 29
putative interactors of InlC or InlC-K224 are shown in boldface type. The data shown are representative of
independent data from three experiments. AU, arbitrary units. (B) Bar plot of the log2-fold changes for the 29
proteins interacting preferentially with InlC or InlC-K224. Negative values indicate a stronger interaction of the
proteins with InlC, and positive values indicate a stronger interaction of the proteins with InlC-K224. Five direct
partners of S100A9 are shown in red. The gray scale indicates adjusted P values. The data shown are representative
of independent data from three experiments.
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nine phosphatases; and TRIM55, a protein with a tripartite motif. These results indicate
that these proteins could be involved in the interaction between InlC and the mam-
malian host alarmin S100A9.
DISCUSSION
During infection, pathogenic bacteria are constantly struggling with their host for
survival and must overcome challenges such as nutritional, innate, and adaptative
immunity. To counteract these defenses, intracellular pathogens have developed so-
phisticated virulence strategies. Some virulence factors target host immune signaling
pathways or interfere with the inflammatory process (31). Other bacterial effectors can
exploit posttranslational modification machineries of the cell for their own benefit to
promote virulence (32–34). However, bacterial effectors can also be modified posttrans-
lationally to be degraded or relocated to contribute to miscellaneous functions (29, 32,
35, 36). Here, we report that the Listeria virulence protein InlC is ubiquitinated at late
time points during cell infection. This modification is a monoubiquitination on the
lysine residue K224. Ubiquitination of bacterial virulence factors can lead to their
proteasomal degradation, which either promotes or limits infection. For instance, the
differential ubiquitination and subsequent degradation of the Salmonella enterica
guanine exchange factor SopE and the GTPase-activating protein SptP allow fine-
tuning of their respective activities, which is important for bacterial invasion into
nonphagocytic cells (37). In contrast, ubiquitination of the Pseudomonas aeruginosa
effector ExoT by the host E3 ligase Cbl-b and its proteasomal degradation limit bacterial
dissemination (38). Besides its role in promoting protein degradation, ubiquitination
has also been shown to affect the function of bacterial effectors. For instance, the
Salmonella phosphoinositide phosphatase SopB is localized at the plasma membrane at
early stages of infection to mediate bacterial entry into cells. At later stages of infection,
SopB relocates to the Salmonella-containing vacuole upon monoubiquitination on
multiple lysine residues by the host E3 ligase TRAF6, promoting intracellular bacterial
replication (29, 39). We demonstrate that ubiquitination of InlC does not lead to its
degradation but promotes its interaction with the alarmin S100A9, a potent modulator
of inflammatory processes (40). This interaction stabilizes S100A9 within the cell, while
the InlC-K224 mutated protein interacts weakly with S100A9, which is rapidly degraded.
InlC ubiquitination and binding to S100A9 occur at late stages of infection compared
to InlC binding to the kinase IKK-, an interaction that dampens the NF-B-dependent
inflammatory process at early stages of infection (16). S100A9 is an important DAMP
with intra- and extracellular effects, e.g., antimicrobial and chemotactic activities.
During infection, bacterial effectors can induce S100A8/S100A9 expression, which is
released by activated phagocytes. Heterodimerization and translocation of S100A9 to
the membrane are facilitated by a protein kinase C-dependent rise in the Ca2 level.
Protein kinase C activation is also required for S100A9 secretion via the microtubule
network (41, 42). In addition, S100A9 can be modified by p38 mitogen-activated protein
kinase-dependent threonine phosphorylation, which abrogates tubulin polymerization
(43). Thus, intracellularly, the interaction of calprotectin, the S100A8/S100A9 het-
erodimer, with microtubules regulated by p38 and Ca2 signaling pathways is critical
for cytoskeleton reorganization and phagocyte migration (43). Extracellularly, S100A8/
S100A9 binds to and activates Toll-like receptor 4 (TLR4) on numerous cell types of the
innate immune system. These activated cells then release inflammatory mediators,
thereby amplifying inflammatory reactions (55). Calprotectin also mediates the produc-
tion of ROS by neutrophils (44, 45). We found that infection with the strain producing
InlC-K224, which leads to rapid S100A9 degradation, triggers weaker ROS production by
neutrophils than the WT strain. Furthermore, this phenotype is abolished in S100A9/
mice, strongly suggesting that the interaction of S100A9 with native InlC could pro-
mote ROS production upon infection.
Although the enzymes catalyzing InlC ubiquitination are currently unknown, we
identified cullin-2 and cullin-5 as putative partners of InlC by an interactomic screen.
Cullin-2 and cullin-5 function as scaffold proteins of cullin-RING E3 ubiquitin ligase (CRL)
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complexes that mediate ubiquitination of target proteins. In CRL2 complexes, cullin-2
assembles with the RING protein Rbx1, the elongin B and C adapter proteins, and
various substrate recognition subunits (SRSs) such as the von Hippel-Lindau (VHL)
tumor suppressor protein (46). CRL2 ligases are involved in multiple biological pro-
cesses, such as development and tumorigenesis, and are subverted by several viruses.
In CRL5 complexes, cullin-5 interacts with the RING protein Rbx2, elongins B and C, and
suppressor of cytokine signaling (SOCS) box-containing proteins (47). As for CRL2, CRL5
ligases regulate multiple signaling pathways, such as cell proliferation and angiogen-
esis, and can be hijacked by viruses. CRL2- and CRL5-interacting proteins have domains
called the VHL box and the SOCS box, respectively. The VHL box is composed of a
cullin-2 box with the consensus sequence PXXXXX (where  can be any hydro-
phobic amino acid) and a BC box that binds elongins B and C and has the consensus
sequence (S/T/P)LXXX(C/S/A)XXX (48). The SOCS box is composed of a BC box and a
cullin-5 box corresponding to the canonical sequence XXLPPXXXX(Y/F)(L/I) (48).
Interestingly, two domains of the InlC sequence have similarity with the consensus
sequences of the BC and cullin boxes (see Fig. S2A in the supplemental material).
Similarly to viral proteins containing VHL or SOCS boxes, such as HIV-1 Vif (49) and the
adenoviral protein E4orf6 (50), InlC could thus form a complex with cullin-2 and/or
cullin-5 during infection. Furthermore, by affinity chromatography, S100A9 was found
to interact with cullin-2 and cullin-5 (51). Interestingly, in cells infected by L. monocy-
togenes expressing InlC lacking the last 33 amino acids, which carry the putative
Cul2/Cul5 boxes, InlC is not ubiquitinated (Fig. S2B). InlC could thus be ubiquitinated by
CRL complexes, thereby stabilizing S100A9.
In conclusion, we have shown that InlC is monoubiquitinated on lysine 224 during
infection. Host ubiquitination of InlC stabilizes S100A9, triggers ROS production by
neutrophils, and restricts infection. Our data reinforce the importance of posttransla-
tional modifications in the subtle regulation of host-pathogen interactions during the
infectious process.
MATERIALS AND METHODS
Cell culture and infection. HeLa (human epithelial cervix carcinoma; ATCC CCL 2) cells and human
kidney HEK-293T cells (Invitrogen) were cultured according to American Type Culture Collection guide-
lines. Cells were generally infected with exponentially growing Listeria strains such that the multiplicity
of infection (MOI) was 50 bacteria per cell (MOI of 50). After 1 h of infection, cells were washed in
phosphate-buffered saline (PBS) and treated with 20 g/ml of gentamicin to prevent the growth of
extracellular bacteria.
Bacterial strains and growth conditions. References and information on strains can be found in
Table S4 in the supplemental material. Listeria strains were grown in brain heart infusion (BHI) broth (BD)
at 37°C at 200 rpm.
Plasmids. References and information on plasmids can be found in Table S5. For mammalian
transfection, the pUC57-FLAG2-InlC, pUC57-FLAG2-InlC-Kall, and pUC57-FLAG2-InlC-K224 plasmids encod-
ing N-terminal FLAG2-tagged InlC sequences were optimized for expression in mammalian cells and
mutated on lysine residues (GeneCust). InlC-Kall refers to the construct where all lysines from K57 to K296
were replaced by arginines, and InlC-K224 refers to lysine 224 replaced by arginine. These constructs were
subcloned into pcDNA3 (Invitrogen) at BamHI/XhoI sites. The yeast two-hybrid screen was performed by
Hybrigenics using plasmids derived from pBTM116 expressing inlC and pGADGH expressing a human
placenta gene bank (16).
The split-nanoluciferase complementation assay (NPCA) to perform the interactome screen is based
on the ability of interacting protein pairs expressed in fusion with the Nlc1 and Nlc2 complementary
fragments of the NanoLuc luciferase to reconstitute an active enzyme. These fragments were positioned
at either the N or C terminus of the selected protein. The ORFs encoding potential factors selected for
the screen, including S100A8 and S100A9 factors, were obtained from the human ORFeome collection
(CCSB, Dana-Farber Institute, Boston, MA, USA) as entry clones in the pDONR223 vector, and they were
fused to the Nlc1 fragment of the luciferase. The InlC plasmids had to be fused to the complementary
Nlc2 fragment positioned at either the N or C terminus of the InlC constructs to subsequently select the
best pairs and obtain the strongest signal in the luciferase assay. The InlC, InlC-Kall, and InlC-K224 ORFs
were amplified by PCR from the respective pUC57 constructs (see above) with oligonucleotides harbor-
ing Gateway recombination attB1.2 and attB2.1 sites listed in Table S6 and cloned by in vitro recombi-
nation into pDONR207 (BP cloning reaction; Invitrogen). Next, the resulting entry clones were transferred
by Gateway recombination into the destination vector pSNL-N2 or pSNL-C2 expressing the Nlc2
fragment of NanoLuc luciferase in fusion at either their N or C termini.
Construction of strains expressing mutated InlC. All PCRs were carried out using the Pfu Turbo
DNA polymerase (Agilent) according to the manufacturer’s recommendations. The inlC gene and its own
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promoter were PCR amplified from the L. monocytogenes EGD chromosome using primers 1 and 2 and
primers 3 and 4, respectively (Table S6), and cloned into the pCR-Blunt vector (Invitrogen) according to
the manufacturer’s recommendations, yielding pBlunt-InlC and pBlunt-InlC-K272,295, respectively (Ta-
ble S5). These plasmids were then used as the templates for PCR site-directed mutagenesis using
overlapping primers, both containing the desired mutation (Table S6). Extension of the primers generates
a mutated pCR-Blunt plasmid containing staggered nicks. PCR products were treated with DpnI to
remove the parental DNA template and then transformed into XL1-Blue electrocompetent cells. Trans-
formants were selected on kanamycin, and plasmids containing the expected punctual mutations were
verified by sequencing using the M13Fw and -Rev primers. The mutated inlC genes encoding InlC
without any lysine residues (InlC-Kall) or without any lysine residues in the LRR region (InlC-KLRR) were
synthesized and cloned into XmaI-SalI-digested plasmid pUC57 (GeneCust, Luxembourg). The SalI-XmaI
restriction fragments, from pBlunt-based or pUC57-based plasmids, composed of either native inlC
(pBlunt-InlC) or mutated inlC were subcloned into the SalI-XmaI-digested pAD2-PinlC-GFP plasmid
(Table S5) (52). All pAD-based plasmids were verified by sequencing using primers pPL2-Rev and
pPL2-Fw and transformed into L. monocytogenes EGD ΔinlC (BUG2117) by electroporation (Table S4).
Integration into the chromosome was verified by PCR amplification using primers NC16 and PL95
(Table S6). For multiple-site mutagenesis, newly synthesized pCR-Blunt-based plasmids containing the
inlC gene with a punctual mutation(s) were used as the templates for subsequent PCR site-directed
mutagenesis as described above (Table S5). For the generation of the L. monocytogenes EGD strain
producing InlC lacking the C terminus, the first 792 nucleotides of the inlC gene and its own promoter
were amplified by PCR from the L. monocytogenes EGD chromosome and cloned into the SmaI/SalI-
digested pAD2-PinlC-GFP plasmid (Table S5). The resulting plasmid, pAD-InlC-T5, was introduced into L.
monocytogenes EGD ΔinlC (BUG2117) by electroporation (Table S4). The chromosomal insertion was
verified by PCR using primers NC16 and PL95 (Table S6).
Immunoblotting. Cells were lysed in Laemmli buffer, and proteins eluted from immunoprecipitation
assay mixtures were separated on SDS-polyacrylamide gels. Proteins were transferred to polyvinylidene
fluoride membranes and incubated with primary antibodies. Membranes were then incubated with
anti-rabbit or anti-mouse horseradish peroxidase (HRP)-conjugated antibodies (AbCys). The blots were
revealed using the ECL kit or ECL-2 kit (Thermo Fisher Scientific) or the Clarity kit (Bio-Rad).
Transfection. HeLa cells were seeded into T75 flasks in complete medium at a density of 2.5  106
cells. Cells were transfected the day after with 15 g of expression plasmids using Lipofectamine LTX
reagents according to the manufacturer’s protocol (Invitrogen). After 24 or 48 h, the transfected cells
were either directly lysed and used for immunoprecipitation assays or infected as described above, and
24 h later, the transfected/infected cells were lysed and processed for immunoprecipitation.
Antibodies. The primary antibodies used in this study were affinity-purified rabbit polyclonal
anti-InlC (R134) (16), mouse antiubiquitin (catalog number 3936; Cell Signaling Technology), rabbit
anti-SUMO1 (catalog number 4930; Cell Signaling Technology), mouse anti-ISG15 (F-9, catalog number
sc166755; Santa Cruz Biotechnology), mouse anti-HA (6E2, catalog number 2367; Cell Signaling Tech-
nology), rabbit anti-HA (C29F4; Cell Signaling Technology), mouse antiactin (AC-15; Sigma-Aldrich), rabbit
anti-S100A9 (catalog number pab0423-P; Covalab), and mouse anti-NF-B-p65 (F6; Santa Cruz).
ELISA. HeLa cells were cultured in 24-well plates according to American Type Culture Collection
guidelines. Cells were transfected with pcDNA3.1/N-HA-S100A9 at 500 ng/well (Table S5). After 48 h,
cells were infected with exponentially growing Listeria strains such that the multiplicity of infection was
60 bacteria per cell. Plates were centrifuged for 5 min at 1,100 rpm at 18°C and incubated at 37°C for 90
min. Cells were washed 3 times in PBS, treated with 20 g/ml of gentamicin, and stimulated with
50 ng/ml of human TNF- (R&D Systems). After 24 h, S100A9 secreted by infected cells was quantitated
by an enzyme-linked immunosorbent assay (ELISA) according to the manufacturer’s recommendations
(DuoSet ELISA S100A9; R&D Systems).
Split-nanoluc luciferase complementation assay. The luciferase protein complementation assay
was performed in a 96-well-plate format (Greiner, Kremsmünster, Austria) using HEK-293T cells (40,000
cells/well plated in 100 l of Dulbecco’s modified Eagle’s medium [DMEM] supplemented with 10% fetal
bovine serum and antibiotics). After 24 h, cells were transfected using a polyethylenimine (PEI) method
with 200 ng total DNA mix containing plasmid pairs respectively encoding the human proteins fused at
the N or C terminus to amino acids 1 to 65 of the nanoluciferase and with a plasmid bearing the N or
C terminus fused to the complementary moieties of luciferase and encoding either S100A9, InlC proteins,
or an irrelevant protein (BCL2-L1) as a negative control. At 24 h posttransfection, the medium of the cells
was harvested, and the cells were incubated with 50 l of Nano-Glo luciferase reagent (Promega).
Luminescence monitoring was performed on a Centro XS3 LB 960 microplate luminometer (Berthold
Technologies) using an integration time of 2 s. After cotransfection of the different constructs, the
highest efficiency of interaction revealed was obtained when these moieties were placed at the C
terminus of S100A9 and InlC, giving the combination C1-S100A9/C2-InlC. For each interaction, P values
were calculated from the means of quadruplicates, using the Holm-Sidak t test.
Immunoprecipitation. Infected or transfected cells were rinsed three times in cold PBS. For
immunoprecipitation of infected cells, cells were lysed for 2 h in modified radioimmunoprecipitation
assay (RIPA) buffer (50 mM Tris-HCl [pH 7.6], 1% NP-40, 0.5% sodium deoxycholate, 150 mM NaCl, 0.1%
sodium dodecyl sulfate, 1 mM EDTA, 20 mM N-ethylmaleimide, and a complete protease inhibitor
cocktail [Roche]). Lysates were centrifuged for 15 min at 4°C at 16,000  g, and supernatants were
incubated for 15 min with protein A-Sepharose beads (GE Healthcare) to eliminate unspecific binding of
proteins to beads. After the removal of the beads, cleared lysates were then incubated overnight at 4°C
with anti-InlC antibodies. The immunocomplexes were then captured by incubating samples for 3 h with
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protein A-Sepharose beads. Beads were finally collected and washed four times in the corresponding
lysis buffer, and captured proteins were eluted using Laemmli buffer. For immunoprecipitation of
FLAG-tagged InlC, cells were lysed for 2 h in FLAG lysis buffer (20 mM Tris-HCl [pH 8.0], 1% Triton, 150 mM
NaCl, and a complete protease inhibitor cocktail [Roche]). Lysates were centrifuged, and 1.5 mg of the
total extract was incubated overnight at 4°C with 15 l of washed anti-FLAG magnetic beads (Sigma-
Aldrich). The immunocomplexes were washed four times with buffer containing 0.25% Triton by using
a magnetic rack, and proteins were eluted twice using 20 l of 3 FLAG peptide (100 g/ml of 3 FLAG
peptide [Sigma-Aldrich] in a solution containing 50 mM Tris-HCl [pH 7.4] and 150 mM NaCl).
Murine infection experiments. L. monocytogenes strains were thawed from glycerol stocks stored
at 80°C, washed, and diluted in PBS before injection. LD50 experiments were carried out by injecting
200-l serial dilutions of the bacterial suspension intravenously in the tail vein of 8-week-old female
BALB/c mice (Charles River). LD50 values were determined by the probit method after infection of groups
of 5 mice. Kaplan-Meier curves were generated by measuring mouse daily survival over 10 days. For
peritoneal infections, a sublethal dose (107 bacteria) was injected into the peritoneal cavity of 8-week-old
female C57BL/6 mice (Charles River) or S100A9/ mice, provided by Thomas Vogl (53). The inoculum
was confirmed by plating serial dilutions of the bacterial suspension on BHI agar plates. For the
determination of bacterial loads, peritoneal lavage fluids were recovered at 24, 48, and 72 h postinfec-
tion. Serial dilutions of organ homogenates were plated on BHI agar plates, and CFU were counted after
growth at 37°C for 48 h. All experiments were performed in accordance with the Institut Pasteur’s
guidelines for laboratory animal welfare. For flow cytometry, peritoneal lavage fluids were washed in
staining buffer (PBS with 0.5% fetal calf serum [FCS] and 2 mM EDTA), counted, and distributed in 96-well
plates for staining. Unspecific binding was blocked by incubation with anti-mouse CD16/CD32 (BD
Biosciences) for 10 min before the addition of surface-labeling antibodies for another 40 min, in staining
buffer at 4°C. Cells were washed twice in PBS before viability dye (eFluor780; eBioscience) labeling for 5
min at 4°C. Cells were washed twice in staining buffer and fixed for 5 min using a commercial fixation
buffer (BioLegend). For intracellular cytokine staining, cells were permeabilized and washed with buffers
from commercial kits (Inside stain kit; Miltenyi Biotec). For interferon gamma (IFN-) detection, samples
were incubated for 4 h at 37°C with brefeldin A (eBioscience) before staining. ROS detection was
performed according to the manufacturer’s instructions (Total ROS assay kit 520 nm; Invitrogen). The
following antibodies (clones) were used: NK1.1 (PK136), CD3 (145-2C11), CD11b (M1/70), CD69 (H1.2F3),
CD25 (PC61), Ly6C (HK1.4), Ly6G (1A8-Ly6g), CD11c (HL3), CD64 (X54-5/7.1), F4/80 (T45-2342), NOS2
(CXNFT), and IFN- (XMG1.2) (purchased from BioLegend, eBioscience, and BD Biosciences). Sample
acquisition was performed on a MACSQuant cytometer (Miltenyi Biotec), and analysis was done using
FlowJo software (TreeStar).
Ethics statement. This study was carried out in strict accordance with French national and European
laws and conformed to the Council Directive on the approximation of laws, regulations, and adminis-
trative provisions of the Member States regarding the protection of animals used for experimental and
other scientific purposes (86/609/EEC). Experiments that relied on laboratory animals were performed in
strict accordance with the Institut Pasteur’s regulations for animal care and use protocol, which was
approved by the Animal Experiment Committee of the Institut Pasteur (approval number 03-49).
Statistical analysis. To compare the interactions between InlC, InlC-K224, and their putative partners,
we performed statistical analysis with the limma package (v3.30.13) and voom transformation (54). The
data were normalized using trimmed mean of M values (TMM) normalization. By shrinking the variance
estimates toward a common value, the linear model implemented in the limma package provides a
robust comparison for each protein between the two conditions InlC and InlC-K224. The resulting P values
were adjusted according to the Benjamini-Yekutieli procedure (56).
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